Glenmark Life Scienc - Quaterly Results

27 Apr 2023 Evaluate
The Revenue for the quarter ended  March 2023 of Rs. 6213.20 millions grew by 20.87 % from Rs. 5140.57 millions.An average growth of 47.99% was recorded for the quarter ended March 2023 to Rs. 1463.57  millions from Rs. 988.97 millions.Operating profit for the quarter ended March 2023 rose to 2092.66 millions as compared to 1473.06 millions of corresponding quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 6213.20 5140.57 20.87 21612.20 21232.14 1.79 21612.20 21232.14 1.79
Other Income 28.36 50.95 -44.34 289.57 147.04 96.93 289.57 147.04 96.93
PBIDT 2092.66 1473.06 42.06 6712.50 6307.64 6.42 6712.50 6307.64 6.42
Interest 1.19 1.25 -4.80 5.47 279.62 -98.04 5.47 279.62 -98.04
PBDT 2091.47 1471.81 42.10 6707.03 6028.02 11.26 6707.03 6028.02 11.26
Depreciation 115.17 95.54 20.55 420.94 378.77 11.13 420.94 378.77 11.13
PBT 1976.30 1376.27 43.60 6286.09 5649.25 11.27 6286.09 5649.25 11.27
TAX 512.73 387.30 32.39 1616.48 1462.01 10.57 1616.48 1462.01 10.57
Deferred Tax 39.62 18.25 117.10 110.37 85.74 28.73 110.37 85.74 28.73
PAT 1463.57 988.97 47.99 4669.61 4187.24 11.52 4669.61 4187.24 11.52
Equity 245.05 245.05 0.00 245.05 245.05 0.00 245.05 245.05 0.00
PBIDTM(%) 33.68 28.66 17.54 31.06 29.71 4.55 31.06 29.71 4.55

Alivus Life Sciences Share Price

907.15 1.75 (0.19%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×